Enugu Opens Multi-Billion-Naira Pharmaceutical Factory to Boost Local Drug Production
ENUGU, Nigeria | October 24, 2026
Enugu State Governor Peter Mbah has commissioned Anchorage Pharmaceutical Industries Limited, a multi-billion-naira pharmaceutical manufacturing company located in the Trans-Ekulu area of Enugu, in a move expected to strengthen local medicine production, create employment opportunities and support healthcare delivery in Nigeria. The facility was inaugurated on Thursday, October 22, 2026, according to reports published by Premium Times and other Nigerian news outlets. The project represents a private-sector investment in the pharmaceutical industry at a time when Nigeria continues to pursue greater domestic production of essential medicines and improved access to healthcare.
Premium Times Nigeria
+2
Speaking at the commissioning ceremony, Mbah described the facility as more than a business venture, saying it represented an investment in public health, economic development and the future of young people in the state. He congratulated the company's founder, board and management, noting that establishing a manufacturing enterprise requires considerable commitment and confidence in the local business environment. Premium Times Nigeria
+1
Government Plans Partnership to Supply Public Health Facilities
The governor disclosed that his administration would explore commercial partnerships with Anchorage Pharmaceutical Industries to supply medicines to the state's Central Medical Stores and primary healthcare facilities.
Mbah said the proposed arrangement could help improve the availability of essential medicines in public health institutions while supporting the growth of a locally based manufacturing company. He emphasised that his government was interested in products manufactured within Enugu and intended to work with private businesses to strengthen the state's economy. Premium Times Nigeria
+1
The governor also highlighted the state's plan to build 260 Type-2 primary healthcare centres across its wards.
According to him, these facilities would require dependable supplies of essential medicines to provide effective services to residents. The proposed partnership could create a market for locally manufactured pharmaceutical products, although the government has not announced a completed supply agreement or disclosed the quantities, prices or specific medicines that might be procured from the company. Company Promises Quality and Regulatory Compliance
The Chairman of Anchorage Pharmaceutical Industries' Board of Directors, Rear Admiral Allison Madueke (retd.), commended the state government for creating what he described as an investment-friendly environment that helped attract the project to Enugu.
Madueke, a former Chief of Naval Staff and former military governor of the old Anambra and Imo states, described the company as a long-term investment intended to generate employment, develop local talent and contribute to economic prosperity. He said the company would prioritise product quality, patient safety, regulatory compliance and sound corporate governance. Premium Times Nigeria
+1
He also acknowledged the role of the National Agency for Food and Drug Administration and Control (NAFDAC) in protecting public health, stressing the importance of maintaining appropriate standards in pharmaceutical manufacturing.
The company's Managing Director, Engineer Chima Madueke, said the business was established around the principles of quality and wellness, reflected in its slogan, “Anchored in Quality, Committed to Wellness.”
According to the managing director, the company had obtained the necessary approvals and clearances from NAFDAC and the Pharmaceutical Society of Nigeria. He said Anchorage was committed to quality assurance and intended to supply hospitals, healthcare institutions, community pharmacies and other pharmaceutical distribution channels. These regulatory claims were attributed to the company at the commissioning ceremony.
Premium Times Nigeria
+1
New Factory Expected to Create Jobs and Develop Skills
Beyond medicine production, the facility is expected to create employment opportunities for residents and provide avenues for professional development within the pharmaceutical sector. Mbah said the company would offer internship placements and facilitate skills transfer, potentially giving young people opportunities to gain practical experience and develop careers without having to leave the state. The investment also aligns with the state government's broader economic strategy, which places emphasis on private-sector participation, industrial development and the creation of opportunities for skilled workers.
For Enugu, the establishment of a pharmaceutical manufacturing facility could support related economic activities, including logistics, distribution, packaging and pharmaceutical sales. The scale of these benefits will depend on the company's production capacity, recruitment plans and ability to sustain operations. However, the company has not publicly disclosed detailed figures on its expected workforce, annual production capacity or the value of medicines it intends to manufacture.
The full economic impact will therefore become clearer as operations develop. Implications for Nigeria's Pharmaceutical Industry
Nigeria's pharmaceutical sector plays a critical role in supplying medicines to hospitals, pharmacies and other healthcare providers. Expanding domestic manufacturing could help diversify medicine supply sources, create skilled jobs and strengthen the country's industrial base.
Local production alone, however, does not automatically guarantee lower medicine prices or eliminate counterfeit and substandard products. These outcomes also depend on manufacturing costs, access to raw materials, distribution systems, effective regulation and consistent quality control. Anchorage Pharmaceutical Industries has stated that it intends to contribute to the fight against fake and substandard medicines.
Achieving that objective will require compliance with applicable standards, proper product registration and effective quality assurance throughout manufacturing and distribution. The commissioning also highlights the potential role of state governments in attracting private investment into sectors that directly affect residents' welfare. Through procurement partnerships, infrastructure support and a predictable regulatory environment, state authorities can help businesses develop while pursuing public health objectives.
Enugu Government Reaffirms Support for Investors
During the ceremony, Mbah reiterated his administration's commitment to working with private businesses, arguing that private capital is important to the state's long-term economic growth. The governor's proposed collaboration with Anchorage would extend government support beyond creating a favourable business environment to exploring commercial opportunities that could serve public institutions. Madueke expressed confidence that the facility would contribute to development in Enugu State, the South-East and Nigeria as a whole.
The company also thanked the governor for commissioning the project and supporting an environment intended to encourage business investment. Premium Times Nigeria
+1
Although the long-term success of the project will depend on its production performance, regulatory compliance, market access and financial sustainability, its opening marks a new development in Enugu's pharmaceutical manufacturing landscape. As the facility begins operations, attention will turn to its ability to produce quality medicines consistently, recruit and train workers, supply healthcare providers and build sustainable commercial relationships.
The commissioning of Anchorage Pharmaceutical Industries therefore represents a new private-sector investment with potential implications for medicine supply, employment and industrial development. Its eventual contribution to Nigeria's healthcare system will depend on how effectively the company translates its stated commitments into reliable production and accessible pharmaceutical products. Sources: Premium Times, The Guardian Nigeria and West African Pilot News.